Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines
- PMID: 9508539
- DOI: 10.1023/a:1018851415704
Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines
Abstract
We examined 13 human gastric carcinoma cell lines for the expression of both c-kit and stem cell factor (SCF). Expression of mRNAs was detected by both Northern blot analysis and reverse transcriptase-polymerase chain reaction (RT-PCR), and expression of translated proteins was detected by western blotting. Using RT-PCR we confirmed the expression of c-kit in five (ECC12, TMK1, MKN7, GCIY, and HGC27) cell lines. Northern blot analysis showed coexpression of both c-kit and SCF in ECC12 and expression of SCF in five other (MKN74, MKN1 OKAJIMA, KATOIII, and TMK1) cell lines. SCF stimulated both tyrosine phosphorylation of c-kit and growth of ECC12, whereas it did not stimulate those of GCIY. The sizes of c-kit transcript and protein in GCIY were slightly smaller than those of the reported ones, suggesting the presence of a biologically inactive truncated form of c-kit in GCIY. The present study suggests that c-kit/SCF system might play an important role in the carcinogenesis and tumor growth of ECC12 and that the truncated form of c-kit in GCIY might not be associated with malignant transformation.
Similar articles
-
KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.Int J Oncol. 2006 Oct;29(4):851-9. Int J Oncol. 2006. PMID: 16964380
-
Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.Cancer Res. 1994 Jun 1;54(11):3049-53. Cancer Res. 1994. PMID: 7514496
-
Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.Br J Cancer. 2000 Apr;82(8):1453-8. doi: 10.1054/bjoc.1999.1076. Br J Cancer. 2000. PMID: 10780526 Free PMC article.
-
C-kit receptors in childhood malignant lymphoblastic cells.Leuk Lymphoma. 1997 Apr;25(3-4):201-16. doi: 10.3109/10428199709114160. Leuk Lymphoma. 1997. PMID: 9168431 Review.
-
The road less travelled: c-kit and stem cell factor.J Neurooncol. 1997 Dec;35(3):327-33. doi: 10.1023/a:1005828921273. J Neurooncol. 1997. PMID: 9440029 Review.
Cited by
-
Lack of CD117 and rare bcl-2 expression in stomach cancer by immunohistochemistry. An immunohistochemical study with review of the literature.Diagn Pathol. 2006 May 16;1:7. doi: 10.1186/1746-1596-1-7. Diagn Pathol. 2006. PMID: 16759362 Free PMC article.
-
Expression of stem cell factor in gastrointestinal stromal tumors: Implications for proliferation and imatinib resistance.Oncol Lett. 2013 Feb;5(2):552-558. doi: 10.3892/ol.2012.1019. Epub 2012 Nov 9. Oncol Lett. 2013. PMID: 23420128 Free PMC article.
-
A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer.Invest New Drugs. 2013 Apr;31(2):390-8. doi: 10.1007/s10637-012-9830-x. Epub 2012 May 22. Invest New Drugs. 2013. PMID: 22615059 Clinical Trial.
-
Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer.Invest New Drugs. 2014 Apr;32(2):261-70. doi: 10.1007/s10637-013-9948-5. Epub 2013 May 12. Invest New Drugs. 2014. PMID: 23665950 Free PMC article. Clinical Trial.
-
Embryonic stem cell markers.Molecules. 2012 May 25;17(6):6196-236. doi: 10.3390/molecules17066196. Molecules. 2012. PMID: 22634835 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials